Literature DB >> 26758490

AN483, a new anti-MRSA compound from Streptomyces sp.

Yun J Kwon1, Mi-Jin Sohn1, Hiroyuki Koshino2, Chang-Jin Kim3, Won-Gon Kim1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26758490     DOI: 10.1038/ja.2015.143

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


× No keyword cloud information.
  12 in total

1.  Adxanthromycin: a new inhibitor of ICAM-1/LFA-1 mediated cell adhesion from Streptomyces sp. NA-148.

Authors:  T Koiwa; T Nakano; S Takahashi; H Koshino; M Yamazaki; T Takashi; A Nakagawa
Journal:  J Antibiot (Tokyo)       Date:  1999-02       Impact factor: 2.649

Review 2.  Antibiotics in the clinical pipeline in 2013.

Authors:  Mark S Butler; Mark A Blaskovich; Matthew A Cooper
Journal:  J Antibiot (Tokyo)       Date:  2013-09-04       Impact factor: 2.649

Review 3.  New drugs for methicillin-resistant Staphylococcus aureus: an update.

Authors:  Krishan Kumar; Sidharth Chopra
Journal:  J Antimicrob Chemother       Date:  2013-02-20       Impact factor: 5.790

4.  Adxanthromycins A and B, new inhibitors of ICAM-1/LFA-1 mediated cell adhesion molecule from Streptomyces sp. NA-148. II. Physico-chemical properties and structure elucidation.

Authors:  S Takahashi; T Nakano; T Koiwa; T Noshita; S Funayama; H Koshino; A Nakagawa
Journal:  J Antibiot (Tokyo)       Date:  2000-02       Impact factor: 2.649

5.  WS9761 A and B: new non-steroidal androgen-receptor antagonists produced by a Streptomyces.

Authors:  Y Hori; Y Abe; H Nakajima; N Shigematsu; S Takase; T Goto; M Okuhara; M Kohsaka
Journal:  J Antibiot (Tokyo)       Date:  1993-12       Impact factor: 2.649

6.  Complestatin exerts antibacterial activity by the inhibition of fatty acid synthesis.

Authors:  Yun-Ju Kwon; Hyun-Ju Kim; Won-Gon Kim
Journal:  Biol Pharm Bull       Date:  2015       Impact factor: 2.233

7.  Adxanthromycins A and B, new inhibitors of ICAM-1/LFA-1 mediated cell adhesion molecule from Streptomyces sp. NA-148. I. Taxonomy, production, isolation and biological activities.

Authors:  T Nakano; T Koiwa; S Takahashi; A Nakagawa
Journal:  J Antibiot (Tokyo)       Date:  2000-01       Impact factor: 2.649

Review 8.  Antibiotics for emerging pathogens.

Authors:  Michael A Fischbach; Christopher T Walsh
Journal:  Science       Date:  2009-08-28       Impact factor: 47.728

Review 9.  Waves of resistance: Staphylococcus aureus in the antibiotic era.

Authors:  Henry F Chambers; Frank R Deleo
Journal:  Nat Rev Microbiol       Date:  2009-09       Impact factor: 60.633

10.  Viridicatumtoxin B, a new anti-MRSA agent from Penicillium sp. FR11.

Authors:  Chang-Ji Zheng; Hyung-Eun Yu; Eun-Hee Kim; Won-Gon Kim
Journal:  J Antibiot (Tokyo)       Date:  2008-10       Impact factor: 2.649

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.